Post by CyGenica Ltd.

We were delighted to welcome Arvind Kannan and Shivank Tripathi from 3i Partners to CyGenica’s R&D Center for Intracellular Therapeutics! The visit offered an opportunity to tour our new research facility and engage in substantive scientific discussions around CyGenica’s platform architecture, emerging data, translational strategy, and long-term vision. It was especially energizing to showcase the science behind GEENIE™, our intracellular #deliveryplatform built to address one of therapeutics’ most enduring bottlenecks: efficient intracellular access. We valued thoughtful, science-led engagement and appreciated 3i’s curiosity, rigor, and interest in transformative innovation. We look forward to continuing the conversation as CyGenica enters its next chapter of growth!🪴 #Therapeutics #BiotechInnovation #DrugDelivery #LifeSciences #ResearchandDevelopment Nusrat Sanghamitra PhD SK Fazlul Krishnan Sean O'Sullivan Bill Liao Sami Mikati Dr Renu Swarup Ashutosh Sharma David Rowan Sharaf Yamani Satya Prakash Dash Rishaad Currimjee Ravikrishna Cherukuri Imran N. Kavya Agarwal JB Michel Michael S. Wyand Binay Khandelwal Caitriona Kelleher Vishnu Das Anita Rehman Ashish Ranjan, Ph.D 3i Partners Celesta Capital Golden Sparrow SOSV VOYAGERS.io DBT BIRAC Venture Center (Official Account) KIIT-Technology Business Incubator Indian National Science Academy - INSA Biotechnology Industry Research Assistance Council (BIRAC)